salbutamol 8 mg gsk
glaxosmithkline gmbh & co. kg (8041694) - salbutamolsulfat - retardtablette - salbutamolsulfat (09051) 9,64 milligramm
salbutamol 4 mg gsk
glaxosmithkline gmbh & co. kg (8041694) - salbutamolsulfat - retardtablette - salbutamolsulfat (09051) 4,82 milligramm
loftan 8mg
glaxosmithkline gmbh & co. kg (8041694) - salbutamolsulfat - retardtablette - teil 1 - retardtablette; salbutamolsulfat (09051) 9,64 milligramm
loftan 4mg
glaxosmithkline gmbh & co. kg (8041694) - salbutamolsulfat - retardtablette - teil 1 - retardtablette; salbutamolsulfat (09051) 4,82 milligramm
qinlock
deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinale stromatumoren - antineoplastische mittel - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.
levetiracetam ametas 250 mg filmtabletten
ametas medical gmbh (8178134) - levetiracetam - filmtablette - 250 mg - teil 1 - filmtablette; levetiracetam (27533) 250 milligramm
ayvakyt
blueprint medicines (netherlands) b.v. - avapritinib - gastrointestinale stromatumoren - andere antineoplastische wirkstoffe, die protein-kinase-inhibitoren - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.
thrombocid - salbe
sigmapharm arzneimittel gmbh & co kg - natrium pentosan polysulfat,7-isopropyl-1,4-dimethylazulen - heparinoid, kombination
amiodaron ebewe 150 mg - konzentrat zur herstellung einer infusionslösung
ebewe pharma ges.m.b.h. nfg.kg - amiodaron hydrochlorid - antiarrhythmics, class ii
levocetirizin genericon 5 mg filmtabletten
genericon pharma gmbh - levocetirizin dihydrochlorid - levocetirizin